Phase III trial reports survival gain for anti-B7-H3 antibody-drug conjugate in relapsed small-cell lung cancer
The TAISHAN-302 study found tambotatug pelitecan improved overall survival, progression-free survival and response…
Health technology, medicine and wellbeing.
10 stories
The TAISHAN-302 study found tambotatug pelitecan improved overall survival, progression-free survival and response…
A phase III trial found that brain MRI surveillance without prophylactic cranial irradiation reduced the risk of…
The da Vinci maker plans a 316,000-square-foot plant in Penang that will begin operating in 2028 and, the company…
The health ministry's first healthcare AI hackathon drew 278 participants from ten countries to work on five diseases…
McCrae Hospitals, spun out of Orion Health, takes over a hospital information system at FV Hospital in Ho Chi Minh City…
Olympus Singapore and a Manila hospital will train endoscopists together, in a country where finding digestive cancers…
VUNO's software quantifies more than 100 regions from a brain scan, and the company presents the clearance as a way…
New Horizon Health's CerviClear is sold as the first urine-based HPV test; a private clinic group will distribute it…
The company says its software reads a chest X-ray in under a minute, and the new money is aimed at markets where…
MiRXES says GASTROClear is the first RNA blood test for early gastric cancer; the money is for the trials and approvals…